Sarepta Therapeutics, Inc.
SRPT· Nasdaq
SRPTSarepta Therapeutics, Inc.
Filed Feb 26, 2015 · 10-K · 57 days after period end · 0001193125-15-063997
| Metric | Q4 2014 | Q4 2013 | Q4 2012 | Q4 2011 |
|---|---|---|---|---|
| Net Income | -$44.42M | -$8.82M | -$62.07M | -$1.41M |
| EPS Diluted | -$1.08 | -$0.23 | -$2.36 | -$0.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sarepta Therapeutics, Inc. · CIK 873303 · Engraved from SEC EDGAR
ended Dec 31, 2014 · filed Feb 26, 2015 · 57 d after period end
